SCHEMBL12643180

SCHEMBL12643180

C=C(C)C(=O)NCCC(=O)NC(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
FAAH O00519 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 1/20 0.38
ALDH1A1 P00352 4/20 0.38
TGFBR1 P36897 1/20 0.38
GAA P10253 1/20 0.37
EPHX1 P07099 1/20 0.37
TSHR P16473 1/20 0.36
RXFP1 Q9HBX9 2/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HSD17B10 Q99714 1/20 0.32
ANPEP P15144 2/20 0.32
RNPEP Q9H4A4 2/20 0.32
DNPEP Q9ULA0 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12333030 0.86 MAPK1 (0.54) MEN1FAAHMAPK1KMT2AEPHX2
SCHEMBL8373364 0.81 TGFBR1 (0.40) MEN1FAAHMAPK1KMT2AALDH1A1
SCHEMBL23011663 0.80 MAPK1 (0.48) MEN1FAAHMAPK1KMT2AEPHX2
SCHEMBL12310159 0.79 LMNA (0.40) ALDH1A1TGFBR1
SCHEMBL2611993 0.77 FAAH (0.44) MEN1FAAHKMT2AEPHX2ALDH1A1
SCHEMBL15535068 0.76 ALDH1A1 (0.41) MAPK1ALDH1A1TGFBR1TSHRKDM4E
SCHEMBL28072647 0.75 TSHR (0.56) MEN1MAPK1KMT2AALDH1A1TGFBR1
SCHEMBL25398029 0.75 TSHR (0.56) MEN1FAAHMAPK1KMT2AALDH1A1
SCHEMBL316224 0.75 TGFBR1 (0.41) MAPK1ALDH1A1TGFBR1TSHRRXFP1
SCHEMBL7052805 0.75 RXFP1 (0.38) MEN1KMT2AALDH1A1TGFBR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110140041-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS, LIQUID CRYSTALLINE POLYMERS AND OPTICALLY ANISOTROPIC MATERIALS ZEON CORPORATION (JP) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110140041-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUNDS, POLYMERIZABLE LIQUID CRYSTAL COMPOSITIONS, LIQUID CRYSTALLINE POLYMERS AND OPTICALLY ANISOTROPIC MATERIALS CCNB1, CCNT1, CCNB2 MEN1 876/4885FAAH 3331/4885MAPK1 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.